The impact of managed care on cancer care. Review and recommendations

Cancer Practice

Volumn 5, Issue 2, 1997, Pages 111-118

  Simmons, W June ^a   Goforth, Lynn ^b  

^a Visiting Nurse Association Foundation   (United States)

^b Lynn Goforth Consulting   (United States)

Author keywords

healthcare delivery; healthcare trends; managed care programs; neoplasms; oncology

Indexed keywords

CANCER; DECISION MAKING; HEALTH CARE; HUMAN; REVIEW;

DELIVERY OF HEALTH CARE; HEALTH CARE COSTS; HUMANS; MANAGED CARE PROGRAMS; MEDICAL ONCOLOGY; NEOPLASMS; ORGANIZATIONAL INNOVATION; REFERRAL AND CONSULTATION; RESEARCH; TERMINAL CARE; UNITED STATES;

EID: 0030907765     PISSN: 10654704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Jennings MC, O'Leary SJ. The role of managed care in integrated delivery networks. J Ambulatory Care Manage 1994; 17:39-47.
2. Kongstvedt PR, ed. Essentials of Managed Health Care. Gaithersburg, MD: Aspen Publishers Inc; 1995.
3. Wagner ER. Types of managed care organizations. In: Kongstvedt PR, ed. Essentials of Managed Health Care. Gaithersburg, MD: Aspen Publishers Inc; 1995:24-34.
4. Presant CA. Oncology in a managed care environment. Oncol Issues 1995; May/June:18-20.
5. McDermott KC. Healthcare reform: past and future. Oncol Nurs Forum 1994; 21:827-832.
6. Rivo ML, Mays HL, Katzoff J, Kindig DA. Managed health care, implications for the physician workforce and medical education. JAMA 1995; 274:712-715.
7. Davis K, Anderson G, Rowland D, Steinberg EP. Health Care Cost Containment. Baltimore, MD: Johns Hopkins University Press; 1990.
8. Keigher SM. Managed care's silent seduction of America and the new politics of choice. Health Social Work 1995; 20:146-151.
9. Starr P. The Social Transformation of American Medicine. New York: Basic Books; 1982.
10. Stoez D. Corporate welfare: the third stage of welfare in the United States. Social Work 1986; 31:245-249.
11. Leyerle B. Moving and Shaking Medicine: The Structure of a Socioeconomic Transformation. Westport, CT: Greenwood Press; 1984.
12. Emmons DW, Simon CJ. Studies in the Socioeconomic Environment of Medicine. Chicago, IL: American Medical Association; 1994.
13. Masters GM. Managed care and competitive warfare in the 1990s. Topics Health Care Financing 1993; 20:vi-viii.
14. Cornelius DS. Managed care and social work: constructing a context and a response. Soc Work Health Care 1994; 20:47-63.
15. Glandon GL, Shapiro RJ. Economic and quality of life outcomes: managed care perspectives. Oncology 1995; 9(11 suppl):111-119.
16. Mechanic D. Managed care: rhetoric and realities. Inquiry 1994; 30:124-128.
17. Friedman E. Capitation, integration, and managed care: lessons from early experiments. JAMA 1996; 275:957-962.
18. Kravitz RL, Greenfield S, Rogers W, et al. Differences in the mix of patients among medical specialities and among systems of care: results from the Medical Outcomes Study. JAMA 1992; 267:1617-1623.
19. Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study: An application of methods for monitoring the results of medical care. JAMA 1989; 262:925-930.
20. Miller RH, Luft HS. Managed care plans: characteristics, growth, and premium performance. Annu Rev Public Health 1994; 15: 437-459.
21. Holtz D. A focus on managed care trends. Florida Nurse 1995; 43:1-16.
22. Kassirer JP. Managed care and the morality of the marketplace. N Engl J Med 1995; 333:50-52.
23. Bailes JS. Reimbursement: Current status and future outlook. Semin Oncol 1994; 21(suppl 7):118-122.
24. Cost of selected diseases. J Natl Cancer Inst 1993; 85:263-269.
25. VanderLaan BF. Oncology Practice and Managed Care. Illinois: Blue Cross Blue Shield, HMO; 1992.
26. Bennett CL, Westerman IL. Economic analysis during phase III clinical trials: who, what, when, where, and why? Oncology 1995; 9(suppl 11):169-175.
27. Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995; 87:417-426.
28. Harvey C. New systems: the restructuring of cancer care delivery and economics. Oncol Nurs Forum 1994; 21:72-77.
29. McIntosh H. Use of treatment guidelines surges as urge to manage care increases. J Natl Cancer Inst 1995; 87:1044-1047.
30. Morreim EH. From advocacy to tenacity: finding the limits. J Am Geriatric Soc 1995; 43:1170-1172.
31. Why oncologists should get involved in practice guidelines development. Oncology 1995; 9:412-415.
32. Rivo ML, Mays HL, Katzoff J, Kindig DA. Managed health care: implications for the physician workforce and medical education. JAMA 1995; 274:712-715.
33. Kassirer JP. Access to specialty care. N Engl J Med 1994; 331: 1151-1153.
34. Ayanian JS, Hauptman PJ, Guadagnoli E, et al. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med 1994; 331:1136-1142.
35. Misener TR, Fuller SG. Testicular versus breast and colorectal cancer screening. Cancer Pract 1995; 3:310-316.
36. 1989 survey of physicians' attitudes and practices in early cancer detection. CA Cancer J Clin 1990; 40:77-101.
37. Ross J. A dangerous domino? Hosp Health Networks 1995; Sept: 34-38.
38. Boehm R, Suissa M, Glick SM. Changes in the nature of inpatient medical services - impact on medical education and patient care. Israel J Med Sci 1994; 30:125-129-
39. Rogers MC, Snyderman R, Rogers EL. Cultural and organizational implications of academic managed-care networks. N Engl J Med 1994; 331:1374-1377.
40. Levey GS. Academic health centers: facing the new reality of a changing health care system. Am J Med 1995; 99:227-230.
41. Govern FS, Coleman CN. Ethical challenges in the era of healthcare reform: a view from academic oncology. J Oncology Manage 1995; Sept/Oct:20-26.
42. Fogelman A, Campbell K, Holmes E, et al. How academic internal medicine can succeed in managed care and capitated environments. Am J Med 1995; 98:321-327.
43. Kassirer JP. Academic medical centers under siege. N Engl J Med 1994; 331:1370-1371.
44. Stanfill P. Debates concerning managed care continue. J Oncol Manage 1993; Jul/Aug:9.
45. Mortenson LE. Health care policies affecting the treatment of patients with cancer and cancer research. Cancer 1994; 74 (7 suppl):2204-2207.
46. Psaty BM, Koepsell TD, Yanez ND, et al. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992: an effect of the major clinical trials on clinical practice? JAMA 1995; 273:1436-1438.
47. Agusti A, Arnau JM, Laporte JR. Clinical trials versus clincial practice in the secondary prevention of myocardial infarction. Eur J Clin Pharmacol 1994; 46:95-99.
48. Coleman T. Health system reform and clinical research. Oncology 1995; 9:118-126.
49. Bernstein AB, Thompson GB, Harlan L. Differences in rates of cancer screening by usual source of medical care: data from the 1987 National Health Interview Survey. Med Care 1991; 29:196-209.
50. Mitnick JS, Vasquez MF, Kronovet SZ, Roses DF. Malpractice litigation involving patients with carcinoma of the breast. J Am Coll Surg 1995; 181:315-321.
51. Brownson RC, Davis JR, Simms SG, Kern TG, Harmon RG. Cancer control knowledge and priorities among primary care physicians. J Cancer Ed 1993; 8:35-41.
52. HMO members vote with their feet: HCFA releases Medicare HMO disenrollment data. Medicare Advocate 1995:2-3.
53. McIntosh H. Managed care brings major changes to cancer care. J Natl Cancer Inst 1995; 87:784-786.
54. Taylor KS. Survey: Oncologists frustrated with managed care hurdles. Hosp Health Networks 1994; 68:78.
55. Bailes JS. Use and coverage of novel cancer agents in managed care. Semin Oncol 1994; 21(6 suppl):34-37.
56. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 1994; 271:1163-1168.
57. Carroll JT, Graner ME. Hospice is managed care. J Home Health Care Pract 1994; 6:49-54.
58. Lewin-VHI, Inc. An Analysis of the Cost Savings of the Medicare Hospice Benefit. Fairfax, VA: Lewin-VHI, Inc; May 2, 1995.
59. Randal J. Hospice services feel the pinch of managed care. J Natl Cancer Inst 1996; 88:860-862.
60. Epstein SS. Evaluation of the national cancer program and proposed reforms. Int J Health Serv 1993; 23:15-44.
61. Dudgeon DJ, Raubertas RF, Doerner K, O'Connor T, Tobin M, Rosenthal SN. When does palliative care begin? A needs assessment of cancer patients with recurrent disease. J Palliative Care 1995; 11:5-9.
62. Kinzbrunner BM. Ethical dilemmas in hospice and palliative care. Support Care Cancer 1995; 3:28-36.
63. Complex patients demand higher-level CMs. Hospital Case Management 1995; Oct:151-153.